Literature DB >> 22972532

Heart rate and blood pressure: any possible implications for management of hypertension?

Scott Reule1, Paul E Drawz.   

Abstract

Hypertension is a common clinical problem and a major risk factor for cardiovascular disease and stroke. Elevated heart rate is associated with elevated blood pressure, increased risk for hypertension, and, among hypertensives, increased risk for cardiovascular disease. Despite these important relationships, heart rate is generally not a major consideration in choosing antihypertensive medications. In part, this is due to a lack of evidence supporting heart rate lowering as a therapeutic strategy in hypertension. Additionally, while there is a positive correlation between heart rate and peripheral blood pressure, there is an inverse relationship between heart rate and central blood pressure. The use of antihypertensive medications, specifically medications that affect heart rate, may not reliably reduce central blood pressure to a similar extent as observed peripherally. We review the relationship between heart rate and peripheral and central blood pressure, with a focus on the implications for chronotropic therapy in hypertension.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22972532      PMCID: PMC3491126          DOI: 10.1007/s11906-012-0306-3

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  59 in total

1.  Usefulness of heart rate to predict cardiac events in treated patients with high-risk systemic hypertension.

Authors:  Stevo Julius; Paolo Palatini; Sverre E Kjeldsen; Alberto Zanchetti; Michael A Weber; Gordon T McInnes; Hans R Brunner; Giuseppe Mancia; M Anthony Schork; Tsushung A Hua; Bjoern Holzhauer; Dion Zappe; Silja Majahalme; Kenneth Jamerson; Nevres Koylan
Journal:  Am J Cardiol       Date:  2011-12-09       Impact factor: 2.778

2.  Do elderly systolic heart failure patients benefit from beta blockers to the same extent as the non-elderly? Meta-analysis of >12,000 patients in large-scale clinical trials.

Authors:  Brian R Dulin; Steven J Haas; William T Abraham; Henry Krum
Journal:  Am J Cardiol       Date:  2005-04-01       Impact factor: 2.778

3.  Dissociation between central augmentation index and carotid-femoral pulse-wave velocity: when and why?

Authors:  Athanase D Protogerou; Michel E Safar
Journal:  Am J Hypertens       Date:  2007-06       Impact factor: 2.689

4.  Should nephrologists use beta-blockers? A perspective.

Authors:  Rigas Kalaitzidis; George Bakris
Journal:  Nephrol Dial Transplant       Date:  2008-12-10       Impact factor: 5.992

Review 5.  Role of elevated heart rate in the development of cardiovascular disease in hypertension.

Authors:  Paolo Palatini
Journal:  Hypertension       Date:  2011-09-06       Impact factor: 10.190

6.  Amlodipine-valsartan combination decreases central systolic blood pressure more effectively than the amlodipine-atenolol combination: the EXPLOR study.

Authors:  Pierre Boutouyrie; Assya Achouba; Patrick Trunet; Stéphane Laurent
Journal:  Hypertension       Date:  2010-04-19       Impact factor: 10.190

7.  Hypertension awareness, treatment, and control in adults with CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study.

Authors:  Paul Muntner; Amanda Anderson; Jeanne Charleston; Zhen Chen; Virginia Ford; Gail Makos; Andrew O'Connor; Kalyani Perumal; Mahboob Rahman; Susan Steigerwalt; Valerie Teal; Raymond Townsend; Matthew Weir; Jackson T Wright
Journal:  Am J Kidney Dis       Date:  2009-12-05       Impact factor: 8.860

8.  Validity of pulse pressure and augmentation index as surrogate measures of arterial stiffness during beta-adrenergic stimulation.

Authors:  Daniel Lemogoum; Gabriella Flores; Wouter Van den Abeele; Agnieszka Ciarka; Marc Leeman; Jean Paul Degaute; Philippe van de Borne; Luc Van Bortel
Journal:  J Hypertens       Date:  2004-03       Impact factor: 4.844

9.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

10.  Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate.

Authors:  Mahboob Rahman; Sara Pressel; Barry R Davis; Chuke Nwachuku; Jackson T Wright; Paul K Whelton; Joshua Barzilay; Vecihi Batuman; John H Eckfeldt; Michael A Farber; Stanley Franklin; Mario Henriquez; Nelson Kopyt; Gail T Louis; Mohammad Saklayen; Carole Stanford; Candace Walworth; Harry Ward; Thomas Wiegmann
Journal:  Ann Intern Med       Date:  2006-02-07       Impact factor: 25.391

View more
  17 in total

1.  The Negative Chronotropic Effect in Rat Heart Stimulated by Ultrasonic Pulses: Role of Sex and Age.

Authors:  Olivia C Coiado; William D O'Brien
Journal:  J Ultrasound Med       Date:  2017-01-10       Impact factor: 2.153

2.  Benefits of continuous positive airway pressure on blood pressure in patients with hypertension and obstructive sleep apnea: a meta-analysis.

Authors:  Wenli Shang; Yingying Zhang; Lu Liu; Fenfen Chen; Guizuo Wang; Dong Han
Journal:  Hypertens Res       Date:  2022-06-14       Impact factor: 3.872

3.  Insights into the molecular mechanisms of stress and inflammation in ageing and frailty of the elderly.

Authors:  Dimitrios Vlachakis; Evangelia I Zacharaki; Eirini Tsiamaki; Maria Koulouri; Sofia Raftopoulou; Louis Papageorgiou; George P Chrousos; John Ellul; Vasileios Megalooikonomou
Journal:  J Mol Biochem       Date:  2017-12-10

4.  Ideal cardiovascular health and resting heart rate in the Multi-Ethnic Study of Atherosclerosis.

Authors:  Olatokunbo Osibogun; Oluseye Ogunmoroti; Erica S Spatz; Oluwaseun E Fashanu; Erin D Michos
Journal:  Prev Med       Date:  2019-11-09       Impact factor: 4.018

5.  The Association Between Heart Rate and Glycemic Status in the National Health and Nutrition Examination Surveys.

Authors:  Sarah S Casagrande; Catherine C Cowie; Jay M Sosenko; Kara Mizokami-Stout; Andrew J M Boulton; Rodica Pop-Busui
Journal:  J Clin Endocrinol Metab       Date:  2020-03-01       Impact factor: 5.958

6.  Wearable sensors enable personalized predictions of clinical laboratory measurements.

Authors:  Jessilyn Dunn; Lukasz Kidzinski; Ryan Runge; Daniel Witt; Jennifer L Hicks; Sophia Miryam Schüssler-Fiorenza Rose; Xiao Li; Amir Bahmani; Scott L Delp; Trevor Hastie; Michael P Snyder
Journal:  Nat Med       Date:  2021-05-24       Impact factor: 53.440

Review 7.  Novel Approaches to Investigate One-Carbon Metabolism and Related B-Vitamins in Blood Pressure.

Authors:  Amy McMahon; Helene McNulty; Catherine F Hughes; J J Strain; Mary Ward
Journal:  Nutrients       Date:  2016-11-11       Impact factor: 5.717

8.  Digital Health: Tracking Physiomes and Activity Using Wearable Biosensors Reveals Useful Health-Related Information.

Authors:  Xiao Li; Jessilyn Dunn; Denis Salins; Gao Zhou; Wenyu Zhou; Sophia Miryam Schüssler-Fiorenza Rose; Dalia Perelman; Elizabeth Colbert; Ryan Runge; Shannon Rego; Ria Sonecha; Somalee Datta; Tracey McLaughlin; Michael P Snyder
Journal:  PLoS Biol       Date:  2017-01-12       Impact factor: 8.029

9.  Radical Scavenger Capacity of Jabuticaba Fruit (Myrciaria cauliflora) and Its Biological Effects in Hypertensive Rats.

Authors:  Camila Gabriela de Souza; Daniela Medeiros Lobo de Andrade; Juliana Bahia Reis Jordão; Renato Ivan de Ávila; Leonardo Luiz Borges; Boniek Gontijo Vaz; Marize Campos Valadares; Eric de Souza Gil; Edemilson Cardoso da Conceição; Matheus Lavorenti Rocha
Journal:  Oxid Med Cell Longev       Date:  2017-12-20       Impact factor: 6.543

10.  Effects of ninety minutes per week of continuous aerobic exercise on blood pressure in hypertensive obese humans.

Authors:  Felipe Lovaglio Belozo; Carlos K Katashima; André V Cordeiro; Luciene Lenhare; Jean F Alves; Vagner Ramon Rodrigues Silva
Journal:  J Exerc Rehabil       Date:  2018-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.